|
Spectrum of activity:
|
Gram-positive
&
Gram-negative
|
|
Details of activity:
|
Active against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Salmonella sp. ; protein synthesis inhibitor; active against strains expressing acetyl transferase (AAC-6')
|
|
Description:
|
Natural product from Micromonospora zionensis; rescues mice from infection with broad-spectrum pathogens but inferior to gentamicin; shows toxicity comparable to gentamicin
|
|
Institute where first reported:
|
Microbiological Sciences, Schering Corporation, USA
|
|
Year first mentioned:
|
1976
|
|
Development status:
|
Experimental
|